Bevacizumab safe for use in Tx of macular degeneration
(HealthDay)—The systemic safety of bevacizumab appears to be similar to that of ranibizumab as intravitreal therapy for neovascular age-related macular degeneration (AMD), according to research published online Sept. 15 ...
Sep 29, 2014
0
0